Matrix Metalloproteinases: Mechanisms, Functions and Therapeutic Potential

A special issue of Biomolecules (ISSN 2218-273X).

Deadline for manuscript submissions: 31 May 2025 | Viewed by 2511

Special Issue Editors


E-Mail Website
Guest Editor
Department of Cancer Biology, Mayo Clinic, Jacksonville, FL 32224, USA
Interests: cancer; matrix metalloproteinases (MMPs); yeast surface display; Protein Engineering; Proteases Inhibitors; targeted therapy; extracellular matrix

E-Mail Website
Guest Editor
Department of Cancer Biology, Mayo Clinic, Jacksonville, FL 32224, USA
Interests: flow cytometry; real-time PCR; immunofluorescence techniques; Western Blot; apoptosis; cell differentiation; analytical chemistry; cell culture; biochemistry

E-Mail Website
Guest Editor
Department of Cancer Biology, Mayo Clinic, Jacksonville, FL 32224, USA
Interests: biochemistry; biophysics; cancer biology; drug discovery; human serum albumin
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Matrix metalloproteinases (MMPs) are a family of zinc-dependent endopeptidases that play pivotal roles in extracellular matrix (ECM) remodeling and degradation. They are involved in a wide range of physiological processes, including tissue repair, embryogenesis, and angiogenesis. However, dysregulation of MMP activity has been implicated in various pathological conditions, such as cancer, cardiovascular diseases, and inflammatory disorders. The multifaceted roles of MMPs in health and disease have made them a focal point of biomedical research.

This Special Issue aims to explore the latest advancements in MMP research, encompassing their molecular mechanisms, regulatory pathways, and functional implications. We invite original research articles, reviews, and perspectives that provide insights into the structural biology of MMPs, their role in tissue homeostasis and disease progression, and the development of MMP inhibitors as therapeutic agents. Through this compilation, we seek to enhance our understanding of MMPs and foster the development of novel therapeutic strategies targeting these versatile enzymes. 

Dr. Alireza Shoari
Dr. Joshua W. Ogony
Dr. Gokara Mahesh
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • matrix metalloproteinases
  • endopeptidases
  • MMP inhibitor
  • tissue homeostasis
  • disease progression

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

37 pages, 12904 KiB  
Review
Targeting Invasion: The Role of MMP-2 and MMP-9 Inhibition in Colorectal Cancer Therapy
by Alireza Shoari, Arghavan Ashja Ardalan, Alexandra M. Dimesa and Mathew A. Coban
Biomolecules 2025, 15(1), 35; https://doi.org/10.3390/biom15010035 - 30 Dec 2024
Cited by 2 | Viewed by 2244
Abstract
Colorectal cancer (CRC) remains one of the most prevalent and lethal cancers worldwide, prompting ongoing research into innovative therapeutic strategies. This review aims to systematically evaluate the role of gelatinases, specifically MMP-2 and MMP-9, as therapeutic targets in CRC, providing a critical analysis [...] Read more.
Colorectal cancer (CRC) remains one of the most prevalent and lethal cancers worldwide, prompting ongoing research into innovative therapeutic strategies. This review aims to systematically evaluate the role of gelatinases, specifically MMP-2 and MMP-9, as therapeutic targets in CRC, providing a critical analysis of their potential to improve patient outcomes. Gelatinases, specifically MMP-2 and MMP-9, play critical roles in the processes of tumor growth, invasion, and metastasis. Their expression and activity are significantly elevated in CRC, correlating with poor prognosis and lower survival rates. This review provides a comprehensive overview of the pathophysiological roles of gelatinases in CRC, highlighting their contribution to tumor microenvironment modulation, angiogenesis, and the metastatic cascade. We also critically evaluate recent advancements in the development of gelatinase inhibitors, including small molecule inhibitors, natural compounds, and novel therapeutic approaches like gene silencing techniques. Challenges such as nonspecificity, adverse side effects, and resistance mechanisms are discussed. We explore the potential of gelatinase inhibition in combination therapies, particularly with conventional chemotherapy and emerging targeted treatments, to enhance therapeutic efficacy and overcome resistance. The novelty of this review lies in its integration of recent findings on diverse inhibition strategies with insights into their clinical relevance, offering a roadmap for future research. By addressing the limitations of current approaches and proposing novel strategies, this review underscores the potential of gelatinase inhibitors in CRC prevention and therapy, inspiring further exploration in this promising area of oncological treatment. Full article
Show Figures

Figure 1

Back to TopTop